TFCP2 Antibody

1. TFCP2 signaling is regulated by circular RNA hsa_circ_0023404 in the cervical cancer. PMID: 29738762
2. TFCP2 acts as a transcription co-factor that stimulates YAP transcription by facilitating YAP binding with YAP binding motif (YBF)-containing transcription factors. PMID: 29091762
3. High expression of CP2c was significantly correlated with patient age, and higher histological grade, stage, and small and large vessel invasion in HCC tissues. PMID: 28412749
4. FQI1 mediates alteration of the tumor epigenome by DNMT1-LSF complex disruption, leading to aberrant DNA methylation and gene expression. PMID: 27845898
5. The results suggest potential roles of LSF (TFCP2 ) as a growth regulator through control of the transcription of p21CIP1 in melanocytes and melanoma cells as well as a biomarker for nevus. PMID: 26506241
6. Complement proteins C7 and CFH control the stemness of liver cancer cells via LSF-1 pathway. PMID: 26723877
7. LSF is an important mediator in colorectal carcinoma tumorigenesis and progression, and LSF expression is an important index for and prognostic prediction. PMID: 25337247
8. Antiproliferative small-molecule inhibitors of transcription factor LSF reveal oncogene addiction to LSF in hepatocellular carcinoma PMID: 22396589
9. Inhibition of MMP-9 significantly abrogated LSF-induced angiogenesis as well as in vivo tumorigenesis, thus reinforcing the role of MMP-9 in facilitating LSF function. PMID: 22167195
10. Data suggest that LSF is a key mediator of the Notch1 signaling pathway, suggesting that it might be a novel therapeutic target for the treatment of hepatocellular carcinoma. PMID: 21876634
11. Study show that CRTR-1 is generally an activator of transcription and that it modulates the activity of other family members, CP2, NF2d9 and altNF2d9, in a cell specific manner. PMID: 20661472
12. The expression of osteopontin (OPN), a gene regulating every step in tumor progression and metastasis, was robustly up-regulated by LSF. PMID: 20404171
13. The human PcG protein dinG interacts with CP2, a mammalian member of the grainyhead-like family of transcription factors, in vitro and in vivo. The functional consequence of this interaction is repression of CP2-dependent transcription PMID: 11865070
14. Mutation of a transcription factor, TFCP2L3, causes progressive autosomal dominant hearing loss, DFNA28 PMID: 12393799
15. Case control study indicates LSF polymorphism may have a moderate protective effect against the risk of Alzheimer's disease. PMID: 12555245
16. CP2 is a major factor in the regulation of globin expression in human and mouse erythroid cells, and CP2 binding to the globin gene promoter is essential for the enhanced transcription of globin genes in erythroid differentiation. PMID: 12661759
17. LBP-1c/CP2/LSF may have a role in Alzheimer's disease PMID: 16272261
18. The functional interaction of CP2 with GATA1 in the regulation of erythroid promoters was studied. PMID: 16648487
19. CP2/LBP-1c/LSF as a factor that likely mediates enhanced transcription of GARS-AIRS-GART in Down syndrome-related Alzheimer disease. PMID: 17902044
20. a novel mechanism by which RNF2 and PHB2 modulate the CP2-mediated transcriptional pathway. PMID: 18629613
21. The protein structure prediction of CP2 family in order to elucidate the molecular mechanism of the CP2-directed regulation of gene expression. PMID: 18787404
22. Activates Exon 1 Enhancer of Pax6 along with Sp1 PMID: 11574690
23. Positively regulates Serum Amyloid A3 (SAA3). Identified as SAA3 Enhancer Factor (SEF). PMID: 10455131

Show More

Hide All

HGNC: 11748

OMIM: 189889

KEGG: hsa:7024

STRING: 9606.ENSP00000257915

UniGene: Hs.48849